TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in